Commentary finds cannabis vaporizers reduce carbon monoxide and respiratory symptoms but are not risk-free for new users | Research

The takeaway

Cannabis vaporizers reduce carbon monoxide exposure, chronic respiratory symptoms, and several toxins compared to smoking while producing similar THC blood levels, but new users of any method still face risks of intense effects and dependence.

Cannabis users considering switching methods, healthcare providers advising on harm reduction, and policymakers.

Vaporizers reduce CO and respiratory symptoms vs. smoking cannabis

What the researchers found

Cannabis vaporizers reduce carbon monoxide emission, chronic respiratory symptoms, and exposure to several toxins while producing similar subjective effects and blood THC concentrations compared to smoking. However, new cannabis users face risks of intense effects, cognitive impairment, and dependence regardless of administration method.

Why it matters

As major health organizations recommend vaporizing over smoking cannabis, this commentary evaluates the evidence behind that recommendation while highlighting that vaporizing is harm reduction, not harm elimination.

The numbers in context

The commentary does not provide pooled data but synthesizes findings across multiple studies showing reduced carbon monoxide and respiratory symptoms with vaporizers.

How the study worked

Commentary reviewing present evidence on the harm reduction potential of cannabis vaping compared to smoking, drawing on published studies of respiratory outcomes, pharmacokinetics, and public health implications.

What this study cannot tell us

Commentary, not a systematic review. Limited long-term data on dried herb vaporizer use. Does not address vaping-associated lung injury from THC e-liquids. Cannabis potency varies across products and devices.

How to read the evidence

Commentary synthesizing existing evidence, not a systematic review.

When this study was published

Published in 2022.

The bigger picture

The distinction between harm reduction for existing smokers and risk introduction for new users is critical: vaporizers may help chronic cannabis smokers reduce respiratory harm, but should not be marketed as making cannabis use safe.

Questions still open

Would long-term dried herb vaporizer use eliminate respiratory risks entirely? Should vaporizers be the recommended method for medical cannabis? How do different vaporizer types compare in safety?

Common questions

Is vaporizing cannabis safer than smoking it?

Evidence suggests vaporizing reduces exposure to carbon monoxide and other toxins and decreases chronic respiratory symptoms compared to smoking, while producing similar THC blood levels. However, it is not risk-free.

Should new cannabis users choose vaporizers?

The harm reduction benefit of vaporizers applies mainly to existing chronic smokers switching methods. New users face risks of intense effects, cognitive impairment, and dependence regardless of how they consume cannabis.

Read the original research

Are vaporizers a lower-risk alternative to smoking cannabis?

Canadian journal of public health = Revue canadienne de sante publique, 113(2), 293-296

View on PubMed ↗Publisher’s paper ↗

Citation

Chaiton, Michael; Kundu, Anasua; Rueda, Sergio; Di Ciano, Patricia. (2022). Are vaporizers a lower-risk alternative to smoking cannabis?. Canadian journal of public health = Revue canadienne de sante publique, 113(2), 293-296. https://doi.org/10.17269/s41997-021-00565-w